qPCR Reagents Market Size (2024 - 2029)

The qPCR reagents market is experiencing growth driven by increased demand for diagnostic tests, particularly due to the COVID-19 pandemic, which highlighted the importance of qPCR in disease diagnosis. This demand surge has positively impacted the market size, although it has since slowed with the decline in COVID-19 cases. The market is expected to continue expanding over the forecast period, supported by the rising prevalence of chronic and infectious diseases and the growing geriatric population, both of which increase the need for genetic and diagnostic tests. Despite these growth drivers, challenges such as the high cost of qPCR equipment and a shortage of technical expertise may hinder market expansion.

Market Size of qPCR Reagents Industry

qPCR Reagents Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
CAGR 7.90 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

qPCR Reagents Market  Major Players

*Disclaimer: Major Players sorted in no particular order

qPCR Reagents Market Analysis

The qPCR reagents market is expected to register a CAGR of 7.9% over the forecast period.

The market for qPCR reagent products has increased as a result of COVID-19, owing mostly to rising demand for polymerase chain reaction tests and a significant increase in the target patient group. The qPCR test, which uses nasopharyngeal swabs or other upper respiratory tract specimens, such as throat swabs or, more recently, saliva for immunology assays, has been the most commonly used and reliable test for COVID-19 diagnosis. As a result, disease diagnosis utilizing qPCR reagents emerged as a primary emphasis for pandemic management. The press release by Cytiva in May 2021 revealed that a qPCR reagent manufacturing company had to immediately raise output 50-fold to satisfy the demand for COVID-19 tests. Thus, during the pandemic, the demand for qPCR reagents tremendously increased, which positively influenced the market's growth. Currently, the market demand has slowed down as the number of COVID-19 has declined. Moreover, it is expected that the market will grow over the forecast period due to the rise in the prevalence of chronic diseases and technological advances in the qPCR test.

The rising incidence of infectious and genetic diseases has increased the demand for diagnostic tests that may help people take precautionary measures. The growing geriatric population has also increased the demand for genetic tests. For instance, according to the Breast Cancer Factsheet Now 2021, around 55,000 women and 370 men in the United Kingdom are diagnosed with breast cancer yearly. Breast cancer has claimed the lives of an estimated 600,000 people in the United Kingdom. This figure is expected to climb to 1.2 million by 2030. Additionally, according to the Australian Federation of AIDS Organizations Report published in November 2022, in 2021, it was estimated that there were 29,460 people with HIV in Australia. Of these 29,460 people, an estimated 91% will have been diagnosed by the end of 2021. Thus, with the growing prevalence of infectious diseases, the demand for diagnostic tests is expected to increase, which propels the growth of the market over the forecast period.

Moreover, the growing geriatric population is expected to support market expansion as this population is more susceptible to infectious and chronic diseases. The increasing geriatric population is likely to increase market growth over the forecast period. For instance, according to the 2022 statistics published by the United Nations Population Fund, in the United States, a large proportion of the living population is aged 15-64 and accounts for 65% in 2022. Furthermore, according to the same source, 17% of the population will be 65 or older in 2022. Thus, infectious diseases are more prevalent in the geriatric population, boosting the demand for qPCR reagents.

Thus, the growing burden of infectious diseases and the ageing population support market expansion over the forecast period. However, the high cost of qPCR equipment and the lack of high technical expertise to operate qPCR equipment have been restraining market growth.

qPCR Reagents Industry Segmentation

As per the scope of the report, a real-time polymerase chain reaction (real-time PCR) or quantitative polymerase chain reaction (qPCR) is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR). It monitors the amplification of a targeted DNA molecule during the PCR. The qPCR Reagents Market is segmented by Detection Method (Dye-Based qPCR Reagents, Probes, and Primer-Based qPCR Reagents), Packaging Type (qPCR Core Kits, and qPCR Mastermixes), End-User (Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value in USD (US Dollar) million for the above segments.

By Detection Method
Dye-Based qPCR Reagents
Probes and Primer-Based qPCR Reagents
By Packaging Type
qPCR Core Kits
qPCR Mastermixes
By End-User
Hospitals & Diagnostic Centers
Research Laboratories & Academic Institutes
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

qPCR Reagents Market Size Summary

The qPCR reagents market is poised for significant growth, driven by the increasing demand for diagnostic tests and technological advancements in the field. The market experienced a surge during the COVID-19 pandemic due to the heightened need for polymerase chain reaction tests, which became the standard for diagnosing the virus. This demand led to a substantial increase in production capabilities among manufacturers. Although the immediate demand has tapered as COVID-19 cases have declined, the market is expected to expand over the forecast period due to the rising prevalence of chronic and infectious diseases, as well as the growing geriatric population. These factors are anticipated to sustain the demand for qPCR reagents, despite challenges such as high equipment costs and the need for specialized technical expertise.

North America dominates the qPCR reagents market, supported by a combination of factors including the high incidence of diseases, an aging population, and ongoing technological innovations. The region's market growth is further bolstered by the increasing prevalence of cancer and other chronic conditions, which necessitate accurate diagnostic solutions. Product launches by key market players, such as the introduction of new dye-based assays and master mixes, are expected to enhance market offerings and drive growth. The competitive landscape is characterized by a few major players with substantial resources for research and development, ensuring their continued dominance in the market. As the demand for early diagnosis and treatment solutions rises, the qPCR reagents market is set to experience robust expansion in the coming years.

Explore More

qPCR Reagents Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Incidence of Infectious Diseases and Genetic Disorders

      2. 1.2.2 Growing Geriatric Population

      3. 1.2.3 Increasing Focus on Human Genome Projects

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Reagents and qPCR Equipment

      2. 1.3.2 Lack of Technical Expertise to Operate the qPCR instrument

    4. 1.4 Porter Five Forces

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - in USD Millions)

    1. 2.1 By Detection Method

      1. 2.1.1 Dye-Based qPCR Reagents

      2. 2.1.2 Probes and Primer-Based qPCR Reagents

    2. 2.2 By Packaging Type

      1. 2.2.1 qPCR Core Kits

      2. 2.2.2 qPCR Mastermixes

    3. 2.3 By End-User

      1. 2.3.1 Hospitals & Diagnostic Centers

      2. 2.3.2 Research Laboratories & Academic Institutes

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

qPCR Reagents Market Size FAQs

The qPCR Reagents Market is projected to register a CAGR of 7.90% during the forecast period (2024-2029)

F. Hoffman-La Roche Ltd, Bio-Rad Laboratories Inc, Sigma-Aldrich Corporation (Merck Kgaa), Thermo Fisher Scientific Inc and Agilent Technologies Inc. are the major companies operating in the qPCR Reagents Market.

qPCR Reagents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)